Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionInvestors Research Corp
Latest Disclosed Ownership18,475 shares
Latest Disclosed Value $ 678,956
Investors Research Corp ownership in NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 3, 2026 - Investors Research Corp filed a 13F-HR form disclosing ownership of 18,475 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $582,886 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 11, 2023 disclosing 0 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). The current value of the position is $661,774 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-03 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 18,475 18,475 679 0.1253
2023-05-11 2023-03-31 13F NOVO-NORDISK A S ADR 670100205 0 -32 -100.00 0 -100.00
2023-02-06 2022-12-31 13F NOVO-NORDISK A S ADR 670100205 32 -34 -51.52 4 -42.86 0.0000
2022-11-10 2022-09-30 13F NOVO-NORDISK A S ADR 670100205 66 32 94.12 7 75.00 0.0021
2022-07-21 2022-06-30 13F NOVO-NORDISK A S ADR 670100205 34 34 4 0.0012
2020-07-21 2020-06-30 13F NOVO-NORDISK A S ADR 670100205 0 -8,530 -100.00 0 -100.00
2020-05-05 2020-03-31 13F NOVO-NORDISK A S ADR 670100205 8,530 -200 -2.29 514 1.78 0.3207
2020-02-11 2019-12-31 13F NOVO-NORDISK A S ADR 670100205 8,730 0 0.00 505 11.97 0.2329
2019-10-22 2019-09-30 13F NOVO-NORDISK A S ADR 670100205 8,730 0 0.00 451 1.12 0.2287
2019-07-08 2019-06-30 13F NOVO-NORDISK A S ADR 670100205 8,730 0 0.00 446 -2.41 0.2329
2019-04-23 2019-03-31 13F NOVO-NORDISK A S ADR 670100205 8,730 0 0.00 457 13.68 0.2437
2019-02-04 2018-12-31 13F NOVO-NORDISK A S ADR 670100205 8,730 0 0.00 402 -2.43 0.2807
2018-11-14 2018-09-30 13F NOVO-NORDISK A S ADR 670100205 8,730 -300 -3.32 412 -0.96 0.2356
2018-08-10 2018-06-30 13F NOVO-NORDISK A S ADR 670100205 9,030 30 0.33 416 -6.09 0.2413
2018-05-09 2018-03-31 13F NOVO-NORDISK A S ADR 670100205 9,000 0 0.00 443 -8.28 0.2694
2018-02-13 2017-12-31 13F NOVO-NORDISK A S ADR 670100205 9,000 9,000 483 0.2987
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.